APhA Applauds CMS Efforts

OCTOBER 01, 2005

The American Pharmacists Association (APhA) praised the Centers for Medicare and Medicaid Services for explaining the marketing guidelines for the Medicare Part D prescription drug benefit and for finding the right balance of applying proper safeguards without restricting pharmacists. Under the new rules, pharmacists can help patients in objectively assessing patients' needs and identifying the plan options that meet those needs.

"Allowing pharmacists to continue to play an advisory role in the care of their patients is critical to the successful implementation of this benefit. Every day, patients trust their pharmacist to help them make medication-related decisions," said John A. Gans, PharmD, executive vice president of APhA.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.